Guardian Wealth Advisors, LLC Vertex Pharmaceuticals Inc Transaction History
Guardian Wealth Advisors, LLC
- $838 Million
- Q3 2024
A detailed history of Guardian Wealth Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Guardian Wealth Advisors, LLC holds 1,045 shares of VRTX stock, worth $486,656. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,045
Previous 1,045
-0.0%
Holding current value
$486,656
Previous $489,000
0.61%
% of portfolio
0.06%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding VRTX
# of Institutions
1,722Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$12.5 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$10.8 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.93 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.5 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.19 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...